These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 8361258)
1. The development of good clinical practice in the EEC and in Germany. Anhalt E Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258 [TBL] [Abstract][Full Text] [Related]
2. Status of the GCP guidelines in Europe. Geussenhainer S Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259 [TBL] [Abstract][Full Text] [Related]
3. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint. Legler UF Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261 [TBL] [Abstract][Full Text] [Related]
4. Inspection of clinical investigations by the German health authorities. Schmidt M Methods Find Exp Clin Pharmacol; 1993 May; 15(4):229-31. PubMed ID: 8361260 [TBL] [Abstract][Full Text] [Related]
5. [Community requirements relating to drugs derived from human blood and plasma]. Brunko P Ann Pharm Fr; 1994; 52(2):89-98. PubMed ID: 7944184 [TBL] [Abstract][Full Text] [Related]
6. European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements. Robertson JS; Cichutek K Dev Biol (Basel); 2000; 104():53-6. PubMed ID: 11713824 [TBL] [Abstract][Full Text] [Related]
7. Establishing pan-European clinical trials: regulatory compliance and other practical considerations. Grienenberger A J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097 [TBL] [Abstract][Full Text] [Related]
9. Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Kern P Parasitol Int; 2006; 55 Suppl():S273-82. PubMed ID: 16338164 [TBL] [Abstract][Full Text] [Related]
10. [European guideline for the quality of non-commercial clinical trials: elegant implementation in the Netherlands via the amended Dutch Medical Research Involving Human Subjects Act]. Cohen AF Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1493-5. PubMed ID: 12924078 [TBL] [Abstract][Full Text] [Related]
11. [Recommendation for studies of optimizing therapy protocols]. Creutzig U; Winkler K Klin Padiatr; 1994; 206(4):191-3. PubMed ID: 7967415 [TBL] [Abstract][Full Text] [Related]
12. [Harmonisation of regulatory requirements for clinical trials on medicinal products for human use in the Directive 2001/20/EC and complementary guidance. Implementation of the 12th Law Amending the German Drug Law]. Geisler I; Hofmann HP; Nickel L Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):141-6. PubMed ID: 15726454 [TBL] [Abstract][Full Text] [Related]
13. [The role of the Danish Medical Products Agency in clinical trials]. Simonsen AC Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821 [TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation in children: how to design a new study. Corbacioglu S; Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241 [TBL] [Abstract][Full Text] [Related]
15. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives]. Englev E; Petersen KP Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823 [TBL] [Abstract][Full Text] [Related]
16. [Differences between clinical trials according to the German law on pharmaceuticals (Arzneimittelgesetz) and trials according to the German law on medical products (Medizinproduktegesetz)]. Krummenauer F Ophthalmologe; 2003 Feb; 100(2):150-4. PubMed ID: 12589461 [TBL] [Abstract][Full Text] [Related]
17. [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)]. Vos EJ; Huitema AD Ned Tijdschr Geneeskd; 2006 Sep; 150(38):2104-7. PubMed ID: 17036864 [TBL] [Abstract][Full Text] [Related]
18. [The role of ethical committees in drug trials performed according to "Good Clinical Practice"]. Kerpel-Fronius S Orv Hetil; 1991 Mar; 132(13):703-5. PubMed ID: 2014128 [TBL] [Abstract][Full Text] [Related]
19. Clinical investigation of medicinal products in the treatment of Parkinson's disease (CPMP note for guidance). European Agency for Evaluation of Medicinal Products. Eur Neuropsychopharmacol; 1999 Sep; 9(5):443-9. PubMed ID: 10523052 [TBL] [Abstract][Full Text] [Related]
20. [Good clinical practice. Requirements for clinical documentation on the introduction of new drugs]. Dirach J Ugeskr Laeger; 1990 Apr; 152(14):992-4. PubMed ID: 2183456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]